Nuclear factor-κB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 35, 2012, Pages 14140-14145

  Yan, Qin ^a   Carmody, Ruaidhri J ^a,b   Qu, Zhonghua ^a   Ruan, Qingguo ^a   Jager, Jennifer ^a   Mullican, Shannon E ^a   Lazar, Mitchell A ^a   Chen, Youhai H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR RECEPTOR COREPRESSOR; TOLL LIKE RECEPTOR 4;

ARTICLE; GENE INSERTION; GENE MUTATION; GENE REPRESSION; GENOMICS; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL;

ACETYLATION; AMINO ACID MOTIFS; ANIMALS; BONE MARROW CELLS; CELL LINE; GENE EXPRESSION; HISTONE DEACETYLASES; IMMUNE TOLERANCE; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B P50 SUBUNIT; NUCLEAR RECEPTOR CO-REPRESSOR 1; SHOCK, SEPTIC; TOLL-LIKE RECEPTOR 4;

MUS;

EID: 84865547244     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1119842109     Document Type: Article

References (34)

1. Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447:972-978. (Pubitemid 46975746)
2. Yamamoto M, et al. (2004) Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430:218-222. (Pubitemid 38902431)
3. Kawai T, Akira S (2006) TLR signaling. Cell Death Differ 13:816-825.
4. Broad A, Jones DE, Kirby JA (2006) Toll-like receptor (TLR) response tolerance: A key physiological "damage limitation" effect and an important potential opportunity for therapy. Curr Med Chem 13:2487-2502. (Pubitemid 44364151)
5. Biswas SK, Lopez-Collazo E (2009) Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol 30:475-487.
6. Brint EK, et al. (2004) ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol 5:373-379. (Pubitemid 38500085)
7. Carmody RJ, Ruan Q, Palmer S, Hilliard B, Chen YH (2007) Negative regulation of toll-like receptor signaling by NF-kappaB p50 ubiquitination blockade. Science 317:675-678. (Pubitemid 47229968)
8. Kinjyo I, et al. (2002) SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17:583-591. (Pubitemid 35351504)
9. Medvedev AE, Sabroe I, Hasday JD, Vogel SN (2006) Tolerance to microbial TLR ligands: Molecular mechanisms and relevance to disease. J Endotoxin Res 12:133-150. (Pubitemid 47487520)
10. Kobayashi K, et al. (2002) IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110:191-202. (Pubitemid 34876547)
11. Kastenbauer S, Ziegler-Heitbrock HW (1999) NF-kappaB1 (p50) is upregulated in lipopolysaccharide tolerance and can block tumor necrosis factor gene expression. Infect Immun 67:1553-1559. (Pubitemid 29144365)
12. Rosenbaum JT, Mandell RB (1983) The effect of endotoxin and endotoxin tolerance on inflammation induced by mycobacterial adjuvant. Yale J Biol Med 56:293- 301.
13. Ziegler-Heitbrock HW (1995) Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45:13-26.
14. Bohuslav J, et al. (1998) Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 102:1645-1652. (Pubitemid 28516249)
15. Myrianthefs P, Styliano W, Venetsanou K, Baltopoulos G (2004) LPS tolerance in septic ICU patients: Laboratory and technical considerations. Surg Infect (Larchmt) 5:63-64, author reply 64-65.
16. Mages J, Dietrich H, Lang R (2007) A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 212:723-737.
17. Ho Sui SJ, et al. (2005) oPOSSUM: Identification of over-represented transcription factor binding sites in co-expressed genes. Nucleic Acids Res 33:3154-3164. (Pubitemid 41194459)
18. Kollipara RK, Perumal NB (2010) Motif prediction to distinguish LPS-stimulated proinflammatory vs. antibacterial macrophage genes. Immunome Res 6:5.
19. Natoli G, Saccani S, Bosisio D, Marazzi I (2005) Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6:439-445. (Pubitemid 41716756)
20. Martone R, et al. (2003) Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 100:12247-12252. (Pubitemid 37271546)
21. Barish GD, et al. (2010) Bcl-6 and NF-kappaB cistromes mediate opposing regulation of the innate immune response. Genes Dev 24:2760-2765.
22. Hargreaves DC, Horng T, Medzhitov R (2009) Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138:129-145.
23. Ramirez-Carrozzi VR, et al. (2009) A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-128.
24. Ziegler-Heitbrock HW, et al. (1994) Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. J Biol Chem 269:17001-17004. (Pubitemid 24204013)
25. Ghisletti S, et al. (2009) Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 23:681-693.
26. HuangW, Ghisletti S, Perissi V, Rosenfeld MG, Glass CK (2009) Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. Mol Cell 35:48-57.
27. Sha WC, Liou HC, Tuomanen EI, Baltimore D (1995) Targeted disruption of the p50 subunit of NF-kappa B leads tomultifocal defects in immune responses. Cell 80:321-330.
28. Alenghat T, et al. (2008) Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology. Nature 456:997-1000.
29. Boone DL, et al. (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5:1052-1060. (Pubitemid 41057725)
30. Wertz IE, et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694 -699.
31. Thomassen E, Renshaw BR, Sims JE (1999) Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily. Cytokine 11:389-399. (Pubitemid 29259633)
32. Wald D, et al. (2003) SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 4:920-927. (Pubitemid 37098664)
33. Nomura F, et al. (2000) Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164:3476-3479. (Pubitemid 30169796)
34. McQuown SC, et al. (2011) HDAC3 is a critical negative regulator of long-term memory formation. J Neurosci 31:764-774.